118 related articles for article (PubMed ID: 10949392)
21. Prognostic value of p53 expression in stage IB1 cervical carcinoma.
Chen HY; Hsu CT; Lin WC; Tsai HD; Chang WC
Gynecol Obstet Invest; 2000; 49(4):266-71. PubMed ID: 10828711
[TBL] [Abstract][Full Text] [Related]
22. [Expression of bcl-2, c-erbB2, and p53 protein in cervical epithelial carcinogenesis].
Tang ZH; Cai QF; Ye XA
Ai Zheng; 2003 Oct; 22(10):1057-61. PubMed ID: 14558950
[TBL] [Abstract][Full Text] [Related]
23. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.
Izawa H; Yonemitsu N; Shin T; Sugihara H
Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions.
Wrone-Smith T; Bergstrom J; Quevedo ME; Reddy V; Gutierrez-Steil C; Nickoloff BJ
J Dermatol Sci; 1999 Jan; 19(1):53-67. PubMed ID: 9890376
[TBL] [Abstract][Full Text] [Related]
25. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome.
Uehara T; Kuwashima Y; Izumo T; Kishi K; Shiromizu K; Matsuzawa M
Eur J Gynaecol Oncol; 1995; 16(6):453-60. PubMed ID: 8536760
[TBL] [Abstract][Full Text] [Related]
26. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
27. Ki-67, cyclin D1, p53 and bcl-2 expression in advanced head and neck cancer.
Nagy B; Tiszlavicz L; Eller J; Molnar J; Thurzo L
In Vivo; 2003; 17(1):93-6. PubMed ID: 12655798
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
Saleh HA; Jackson H; Banerjee M
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
[TBL] [Abstract][Full Text] [Related]
29. The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer.
Tjalma WA; Weyler JJ; Bogers JJ; Pollefliet C; Baay M; Goovaerts GC; Vermorken JB; van Dam PA; van Marck EA; Buytaert PM
Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):223-30. PubMed ID: 11451553
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix.
Kanai M; Shiozawa T; Xin L; Nikaido T; Fujii S
Cancer; 1998 May; 82(9):1709-19. PubMed ID: 9576293
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer.
Paik KH; Park YH; Ryoo BY; Yang SH; Lee JC; Kim CH; Ki SS; Kim JM; Park MJ; Ahn HJ; Choi W; Chung JH
J Korean Med Sci; 2006 Feb; 21(1):35-9. PubMed ID: 16479062
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma.
Klatka J
Eur Arch Otorhinolaryngol; 2001 Dec; 258(10):537-41. PubMed ID: 11829192
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of expression of p53 protein and Ki-67 antigen in well-differentiated squamous cell carcinoma of the skin.
Shimizu T; Murakami T; Oga A; Furumoto H; Nakano J; Muto M
J Dermatol; 1999 Dec; 26(12):837-40. PubMed ID: 10659509
[No Abstract] [Full Text] [Related]
34. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.
Grossi F; Loprevite M; Chiaramondia M; Ceppa P; Pera C; Ratto GB; Serrano J; Ferrara GB; Costa R; Boni L; Ardizzoni A
Eur J Cancer; 2003 Jun; 39(9):1242-50. PubMed ID: 12763212
[TBL] [Abstract][Full Text] [Related]
35. The role of p53, Bcl-2 and Ki-67 in premalignant cervical lesions and cervical cancer.
Türkçüoğlu I; Tezcan S; Kaygusuz G; Atabekoğlu CS; Ortaç F; Güngör M; Kankaya D; Sertçelik A
Eur J Gynaecol Oncol; 2007; 28(4):290-3. PubMed ID: 17713095
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
Jain D; Srinivasan R; Patel FD; Kumari Gupta S
Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
[TBL] [Abstract][Full Text] [Related]
38. [Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis].
Dornelas MT; Rodrigues MF; Machado DC; Gollner AM; Ferreira AP
An Bras Dermatol; 2009; 84(5):469-75. PubMed ID: 20098848
[TBL] [Abstract][Full Text] [Related]
39. Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.
Sultana H; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Sato S; Kamazawa S; Ohwada M; Suzuki M; Terakawa N
Ann Oncol; 2003 Feb; 14(2):214-9. PubMed ID: 12562647
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation.
Rödel C; Grabenbauer GG; Rödel F; Birkenhake S; Kühn R; Martus P; Zörcher T; Fürsich D; Papadopoulos T; Dunst J; Schrott KM; Sauer R
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1213-21. PubMed ID: 10725634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
